Patents
Electroporation therapy patents announced; company provides update
Published in Vaccine Weekly, February 18th, 2004
The first, U.S. patent number 6,578,558, entitled "Method and apparatus for reducing electroporation-mediated muscle reaction and pain response," includes claims to use less severe methods for delivering an agent, such as a drug or polynucleotide, into a cell. This patent enhances the intellectual property for the oncology, gene therapy, and DNA vaccine applications of electroporation therapy (EPT).
The second patent, U.S. patent number 6,678,566, entitled "Electrical field therapy with reduced histopathological change in muscle," includes claims to methods for reducing changes...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-02-18)
More Articles from Vaccine Weekly
- Colorectal Cancer
Plant-produced colorectal cancer antigen developed - Cancer Therapy
Cancer vaccine using low affinity epitopes proves successful in mice - Cancer Vaccine
DNA induces T helper type 1-mediated responses in antigen-primed mice - Cancer Vaccine
Researcher reviews novel cancer vaccines - Cardiology
Blood test for heart attack may be sold - Childhood Immunization
Call for increase in flu vaccination among young children - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
